Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$3.0 million.

  • iSpecimen's Free Cash Flow fell 14881.88% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 5309.5%. This contributed to the annual value of -$8.9 million for FY2024, which is 687.09% up from last year.
  • Per iSpecimen's latest filing, its Free Cash Flow stood at -$3.0 million for Q3 2025, which was down 14881.88% from -$192234.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Free Cash Flow ranged from a high of $79015.0 in Q4 2023 and a low of -$6.4 million during Q3 2021
  • Over the past 5 years, iSpecimen's median Free Cash Flow value was -$2.3 million (recorded in 2024), while the average stood at -$2.3 million.
  • As far as peak fluctuations go, iSpecimen's Free Cash Flow skyrocketed by 10483.64% in 2023, and later tumbled by 470403.21% in 2024.
  • iSpecimen's Free Cash Flow (Quarter) stood at -$1.6 million in 2021, then dropped by 0.61% to -$1.6 million in 2022, then surged by 104.84% to $79015.0 in 2023, then plummeted by 4704.03% to -$3.6 million in 2024, then grew by 16.57% to -$3.0 million in 2025.
  • Its Free Cash Flow stands at -$3.0 million for Q3 2025, versus -$192234.0 for Q2 2025 and -$1.1 million for Q1 2025.